John W Beck's Net Worth

$1.3 Million

Estimate Recalculated Nov 1, 2024 04:40AM EST

Who is John W Beck?

John W Beck has an estimated net worth of $1.3 Million. This is based on reported shares across multiple companies, which include RITTER PHARMACEUTICALS INC, ARTELO BIOSCIENCES, INC., Ardea Biosciences, Inc./DE, and METABASIS THERAPEUTICS INC.

SEC CIK

John W Beck's CIK is 0001292404

Past Insider Trading and Trends

2008 was John W Beck's most active year for acquiring shares with 6 total transactions. John W Beck's most active month to acquire stocks was the month of April. 2012 was John W Beck's most active year for disposing of shares, totalling 12 transactions. John W Beck's most active month to dispose stocks was the month of May. 2012 saw John W Beck paying a total of $399,964.48 for 28,048 shares, this is the most they've acquired in one year. In 2012 John W Beck cashed out on 336,707 shares for a total of $5,906,688.54, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RITTER PHARMACEUTICALS INC (QLGN) Snapshot price: $0.154

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
May 23
Form 3
—
0
—
—
0
No matching records found

ARTELO BIOSCIENCES, INC. (ARTL) Snapshot price: $1.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Ardea Biosciences, Inc./DE No price found

SVP, Finance & Operations, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.41K
$32.00
-$141,088.00
0
Jun 19
Form 4
—
0
$23.12
-$496,730.08
4.41K
Jun 11
Form 4
—
0
$19.36
-$163,251.20
4.41K
Scheduled
Jul 25
Form 4
—
0
$15.59
-$48,668.04
4.41K
Scheduled
May 16 - May 17
Form 4
—
0
$16.23
-$155,712.00
4.41K
Scheduled
Feb 15
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
$14.42
-$128,480.30
3.09K
Scheduled
May 14
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
$13.00
-$35,759.75
885
Scheduled
Aug 14
Form 4
—
0
$10.41
-$45,617.00
885
May 20
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
Jan 2
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 15
No matching records found

METABASIS THERAPEUTICS INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 2
Form 4
-1.42%
-3.40K
$8.07
-$27,446.33
236.23K
Scheduled
Jun 19
Form 4
-100.00%
-10.04K
$8.00
-$80,284.00
0
Scheduled
Jun 1
Form 4
-0.13%
-300.00
$8.00
-$2,400.00
239.63K
Scheduled
May 22
Form 4
-1.36%
-3.30K
$8.13
-$26,829.00
239.93K
Scheduled
Apr 25
Form 4
-44.36%
-8.00K
$8.00
-$64,000.00
10.04K
Scheduled
Apr 9 - Apr 10
Form 4
—
0
—
—
0
Mar 7
Form 4
-5.25%
-1.00K
$8.00
-$8,000.00
18.04K
Scheduled
Mar 1
Form 4
-1.34%
-3.30K
$8.00
-$26,400.00
243.23K
Scheduled
Feb 26
Form 4
-32.10%
-9.00K
$8.00
-$72,000.00
19.04K
Scheduled
Dec 5
Form 4
-0.20%
-500.00
$8.01
-$4,006.00
244.09K
Scheduled
Nov 27
Form 4
-24.30%
-9.00K
$8.00
-$72,000.00
28.04K
Scheduled
Nov 8
Form 4
—
0
—
—
0
Mar 19
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
May 18
Form 3
—
0
—
—
0
No matching records found